{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:52:59Z","timestamp":1789750379758,"version":"4.0.1"},"reference-count":194,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neurot.2026.e00925","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:50:19Z","timestamp":1778874619000},"page":"e00925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sex-specific considerations in migraine therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Eloisa","family":"Rubio-Beltran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e00925_bib1","series-title":"Headache classification committee of the international headache society (IHS) the international classification of headache disorders","first-page":"1","volume":"vol. 38","year":"2018"},{"key":"10.1016\/j.neurot.2026.e00925_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.549038","article-title":"Giving researchers a headache - sex and gender differences in migraine","volume":"11","author":"Al-Hassany","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib3","doi-asserted-by":"crossref","first-page":"102348","DOI":"10.1016\/j.xcrm.2025.102348","article-title":"et al. Global,regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: a global burden of disease study 2021","volume":"6","author":"Wijeratne","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.neurot.2026.e00925_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1474-4422(16)30293-9","article-title":"Sex differences in the epidemiology, clinical features, and pathophysiology of migraine","volume":"16","author":"Vetvik","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib5","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/head.12150","article-title":"Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American migraine prevalence and prevention (AMPP) study","volume":"53","author":"Buse","year":"2013","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jnr.23903","article-title":"Sex-related influences in migraine","volume":"95","author":"Pavlovic","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurot.2026.e00925_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1212\/01.WNL.0000130338.62037.CC","article-title":"Migraine prevalence in male to female transsexuals on hormone therapy","volume":"63","author":"Pringsheim","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","article-title":"On behalf of lifting the burden: the global campaign against H. Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019","volume":"21","author":"Steiner","year":"2020","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib9","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/ene.15778","article-title":"Sex differences in clinical characteristics of migraine and its burden: a population-based study","volume":"30","author":"Chalmer","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/head.14488","article-title":"Sex differences in migraine attack characteristics: a longitudinal E-diary study","volume":"63","author":"Verhagen","year":"2023","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0333102414559735","article-title":"Gender influences headache characteristics with increasing age in migraine patients","volume":"35","author":"Bolay","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib12","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/STROKEAHA.111.632547","article-title":"Sex differences in long-term outcomes after stroke","volume":"43","author":"Gall","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2026.e00925_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b3914","article-title":"Migraine and cardiovascular disease: systematic review and meta-analysis","volume":"339","author":"Sch\u00fcrks","year":"2009","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.neurot.2026.e00925_bib14","article-title":"Migraine and risk of cardiovascular disease in women: prospective cohort study","volume":"353","author":"Kurth","year":"2016","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.neurot.2026.e00925_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0333102420974362","article-title":"Sex differences in prevalence of migraine trigger factors: a cross-sectional study","volume":"41","author":"van Casteren","year":"2021","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0333102413507637","article-title":"Prevalence of menstrual migraine: a population-based study","volume":"34","author":"Vetvik","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10194-010-0197-0","article-title":"Self-reported menstrual migraine in the general population","volume":"11","author":"Vetvik","year":"2010","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1177\/03331024221099031","article-title":"Validation of diagnostic ICHD-3 criteria for menstrual migraine","volume":"42","author":"Verhagen","year":"2022","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib19","doi-asserted-by":"crossref","first-page":"e1661","DOI":"10.1212\/WNL.0000000000012723","article-title":"Comparing perimenstrual and nonperimenstrual migraine attacks using an e-Diary","volume":"97","author":"van Casteren","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0333102409359315","article-title":"Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine","volume":"30","author":"Pinkerman","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1468-2982.2004.00741.x","article-title":"Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres","volume":"24","author":"Granella","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1526-4610.2010.01625.x","article-title":"Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial","volume":"50","author":"MacGregor","year":"2010","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s10194-015-0503-y","article-title":"Burden of migraine related to menses: results from the AMPP study","volume":"16","author":"Pavlovi\u0107","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1526-4610.2005.05064.x","article-title":"Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study","volume":"45","author":"Dowson","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1468-2982.2003.00480.x","article-title":"Course of migraine during pregnancy and postpartum: a prospective study","volume":"23","author":"Sances","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib26","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/WNL.0000000000001954","article-title":"Acute headache diagnosis in pregnant women: a hospital-based study","volume":"85","author":"Robbins","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1468-2982.2000.00112.x","article-title":"Migraine with aura and reproductive life events: a case control study","volume":"20","author":"Granella","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1468-2982.1995.015002140.x","article-title":"Sex-Hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without Aura","volume":"15","author":"Cupini","year":"1995","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2003.03092.x","article-title":"Migraine prevalence during menopausal transition","volume":"43","author":"Wang","year":"2003","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/head.12763","article-title":"Perimenopause and menopause are associated with high frequency headache in women with migraine: results of the American migraine prevalence and prevention study","volume":"56","author":"Martin","year":"2016","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102409355601","article-title":"Migraine prevalence by age and sex in the United States: a life-span study","volume":"30","author":"Victor","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0333102416653234","article-title":"Changes in migraine before and after menopause in Japanese climacteric women","volume":"37","author":"Makita","year":"2017","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-5122(93)90121-W","article-title":"Characteristics of headache at menopause: a clinico-epidemiologic study","volume":"17","author":"Neri","year":"1993","journal-title":"Maturitas"},{"key":"10.1016\/j.neurot.2026.e00925_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10194-012-0475-0","article-title":"Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women","volume":"13","author":"Karl\u0131","year":"2012","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1526-4610.1993.hed3307385.x","article-title":"Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women","volume":"33","author":"Granella","year":"1993","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1526-4610.2003.03005.x","article-title":"Hormonal factors in migraine: a population-based study of women aged 40 to 74 years","volume":"43","author":"Mattsson","year":"2003","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-9378(12)90816-9","article-title":"Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age","volume":"168","author":"Oldenhave","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.neurot.2026.e00925_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1526-4610.2003.03065.x","article-title":"Medical oophorectomy with and without estrogen add-back therapy in the prevention of Migraine headache","volume":"43","author":"Martin","year":"2003","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nicl.2017.01.019","article-title":"Grey matter alterations in migraine: a systematic review and meta-analysis","volume":"14","author":"Jia","year":"2017","journal-title":"Neuroimage, Clin"},{"key":"10.1016\/j.neurot.2026.e00925_bib40","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/brain\/aws175","article-title":"Her versus his migraine: multiple sex differences in brain function and structure","volume":"135","author":"Maleki","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2026.e00925_bib41","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","article-title":"Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen","volume":"67","author":"MacGregor","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/WNL.22.4.355","article-title":"The role of estradiol withdrawal in the etiology of menstrual migraine","volume":"22","author":"Somerville","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1526-4610.1972.hed1203093.x","article-title":"The influence of progesterone and estradiol upon migraine","volume":"12","author":"Somerville","year":"1972","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000001142","article-title":"Reduced trigeminovascular cyclicity in patients with menstrually related migraine","volume":"84","author":"Ibrahimi","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.0000000000002798","article-title":"Sex hormones in women with and without migraine: evidence of migraine-specific hormone profiles","volume":"87","author":"Pavlovi\u0107","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib46","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/ejn.16087","article-title":"Sex and stress hormone dysregulation as clinical manifestations of hypothalamic function in migraine disorder: a meta-analysis","volume":"58","author":"Beech","year":"2023","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurot.2026.e00925_bib47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1468-2982.1990.1003147.x","article-title":"Ovarian steroid levels in migraine with and without aura","volume":"10","author":"Nagel-Leiby","year":"1990","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib48","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1212\/WNL.0000000000005855","article-title":"Female sex hormones in men with migraine","volume":"91","author":"van Oosterhout","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib49","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.4081\/ni.2019.8079","article-title":"Testosterone levels in men with chronic migraine","volume":"11","author":"Shields","year":"2019","journal-title":"Neurol Int"},{"key":"10.1016\/j.neurot.2026.e00925_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jocn.2017.11.011","article-title":"Changes in hormones of the hypothalamic-pituitary-gonadal axis in migraine patients","volume":"50","author":"Li","year":"2018","journal-title":"J Clin Neurosci : Off J Neurosurg Soc Austral"},{"key":"10.1016\/j.neurot.2026.e00925_bib51","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fneur.2025.1648017","article-title":"Sex hormone profiles in men with migraine: a cross-sectional, matched cohort study","volume":"16","author":"Triller","year":"2025","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s10194-024-01889-x","article-title":"Hallmarks of primary headache: part 1 \u2013 migraine","volume":"25","author":"Raggi","year":"2024","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0333102417739584","article-title":"Gender aspects of CGRP in migraine","volume":"39","author":"Labastida-Ramirez","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib54","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1523\/JNEUROSCI.0364-19.2019","article-title":"Dural calcitonin gene-related peptide produces female-specific responses in rodent migraine models","volume":"39","author":"Avona","year":"2019","journal-title":"J Neurosci : Off J Soc Neurosci"},{"key":"10.1016\/j.neurot.2026.e00925_bib55","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1526-4610.2007.00714.x","article-title":"Sensitization of the trigeminal sensory system during different stages of the rat estrous cycle: implications for menstrual migraine","volume":"47","author":"Martin","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365519009091595","article-title":"Hormonal influence on calcitonin gene-related peptide in man: effects of sex difference and contraceptive pills","volume":"50","author":"Valdemarsson","year":"1990","journal-title":"Scand J Clin Lab Investig"},{"key":"10.1016\/j.neurot.2026.e00925_bib57","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/bmj.293.6558.1329","article-title":"Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy","volume":"293","author":"Stevenson","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/j.neurot.2026.e00925_bib58","first-page":"146","article-title":"Relationship between sex hormone levels and blood calcitonin gene-related peptide\/endothelin-1 in postmenopausal women with coronary heart disease","volume":"26","author":"Ma","year":"2001","journal-title":"Hunan yi ke da xue xue bao"},{"key":"10.1016\/j.neurot.2026.e00925_bib59","doi-asserted-by":"crossref","first-page":"e1825","DOI":"10.1212\/WNL.0000000000207114","article-title":"Sex hormones and calcitonin gene\u2013related peptide in women with migraine","volume":"100","author":"Raffaelli","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.maturitas.2020.12.012","article-title":"Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman\u2019s life: implications for the efficacy and safety of novel antimigraine medications","volume":"145","author":"de Vries","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.neurot.2026.e00925_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s10194-018-0893-8","article-title":"PACAP38 and PAC1 receptor blockade: a new target for headache?","volume":"19","author":"Rubio-Beltran","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib62","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/0333102416668659","article-title":"The influence of migraine and female hormones on capsaicin-induced dermal blood flow","volume":"37","author":"Ibrahimi","year":"2017","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.neurot.2026.e00925_bib64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s10194-024-01724-3","article-title":"Influence of metabolic state and body composition on the action of pharmacological treatment of migraine","volume":"25","author":"Bruijn","year":"2024","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/humupd\/dmw045","article-title":"Ovarian hormones and obesity","volume":"23","author":"Leeners","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.neurot.2026.e00925_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s10194-015-0510-z","article-title":"Migraine and body mass index categories: a systematic review and meta-analysis of observational studies","volume":"16","author":"Ornello","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib67","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/WNL.0000000000003919","article-title":"Body composition status and the risk of migraine: a meta-analysis","volume":"88","author":"Gelaye","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib68","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/WNL.0b013e3182a824f7","article-title":"Episodic migraine and obesity and the influence of age, race, and sex","volume":"81","author":"Peterlin","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10194-020-01163-w","article-title":"Migraine, obesity and body fat distribution - a population-based study","volume":"21","author":"Kristoffersen","year":"2020","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib70","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/head.12978","article-title":"Menstrual migraine and treatment options: review","volume":"57","author":"Maasumi","year":"2017","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s10194-023-01699-7","article-title":"Health equity, care access and quality in headache \u2013 part 2","volume":"24","author":"Raffaelli","year":"2023","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2026.e00925_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10072-014-1744-2","article-title":"Migraine in pregnancy and lactation","volume":"35","author":"MacGregor","year":"2014","journal-title":"Neurol Sci : Off J Ital Neurol So Ital Soc Clin Neurophysiol"},{"key":"10.1016\/j.neurot.2026.e00925_bib73","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s10194-017-0816-0","article-title":"Headache and pregnancy: a systematic review","volume":"18","author":"Negro","year":"2017","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib74","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00228-014-1748-0","article-title":"Breastfeeding and migraine drugs","volume":"70","author":"Davanzo","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.neurot.2026.e00925_bib75","article-title":"International headache society global practice recommendations for the acute pharmacological treatment of migraine","volume":"44","author":"Puledda","year":"2024","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0049-3848(83)90134-2","article-title":"The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects","volume":"29","author":"Buchanan","year":"1983","journal-title":"Thromb Res"},{"key":"10.1016\/j.neurot.2026.e00925_bib77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-2982.1982.0202071.x","article-title":"Aspirin treatment of migraine attacks: clinical observations","volume":"2","author":"Ross-Lee","year":"1982","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib78","article-title":"Experimental pain in healthy human subjects: gender differences in nociception and in response to ibuprofen","volume":"86","author":"Walker","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neurot.2026.e00925_bib79","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3748\/wjg.v16.i15.1896","article-title":"Gender differences of low-dose aspirin-associated gastroduodenal ulcer in Japanese patients","volume":"16","author":"Okada","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.neurot.2026.e00925_bib80","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3109\/00365521.2010.510567","article-title":"Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding","volume":"45","author":"\u00c5hsberg","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.neurot.2026.e00925_bib81","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s10194-023-01625-x","article-title":"Comparative efficacy of different treatments for menstrual migraine: a systematic review and network meta-analysis","volume":"24","author":"Zhang","year":"2023","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib82","first-page":"176","article-title":"Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo","volume":"5","author":"Al-Waili","year":"2000","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.neurot.2026.e00925_bib83","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","article-title":"Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials","volume":"114","author":"Mannix","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.neurot.2026.e00925_bib84","first-page":"368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"BMJ (Clin Res ed)"},{"key":"10.1016\/j.neurot.2026.e00925_bib85","doi-asserted-by":"crossref","first-page":"228.e1","DOI":"10.1016\/j.ajog.2011.11.019","article-title":"Nonsteroidal antiinflammatory drug use among women and the risk of birth defects","volume":"206","author":"Hernandez","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.neurot.2026.e00925_bib86","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/AOG.0b013e3182595671","article-title":"Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion","volume":"120","author":"Edwards","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.neurot.2026.e00925_bib87","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrneurol.2015.29","article-title":"Pharmacological treatment of migraine during pregnancy and breastfeeding","volume":"11","author":"Amundsen","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib88","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/head.12540","article-title":"Pregnancy and lactation--migraine management","volume":"55","author":"Tepper","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib89","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00023210-200519060-00001","article-title":"Migraine during pregnancy: options for therapy","volume":"19","author":"Fox","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurot.2026.e00925_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108210","article-title":"Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years","volume":"9","author":"Thompson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e00925_bib91","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/ije\/dyt183","article-title":"Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study","volume":"42","author":"Brandlistuen","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.neurot.2026.e00925_bib92","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","article-title":"Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders","volume":"168","author":"Liew","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.neurot.2026.e00925_bib93","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"CMAJ (Can Med Assoc J) : Canad Med Asso J = journal de l\u2019Association medicale canadienne"},{"key":"10.1016\/j.neurot.2026.e00925_bib94","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/aogs.14557","article-title":"Paracetamol use in pregnancy: not as safe as we may think?","volume":"102","author":"Nilsen","year":"2023","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.neurot.2026.e00925_bib95","unstructured":"Agency EM. Pharmacovigilance risk assessment committee (PRAC) \u2013 minutes of the meeting on 5-8 May 2014: PRAC, Available from: https:\/\/www.ema.europa.eu\/en\/documents\/minutes\/minutes-prac-meeting-5-8-may-2014_en.pdf."},{"key":"10.1016\/j.neurot.2026.e00925_bib96","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0890334417695207","article-title":"Transfer of low dose aspirin into human milk","volume":"33","author":"Datta","year":"2017","journal-title":"J Hum Lactation"},{"key":"10.1016\/j.neurot.2026.e00925_bib97","series-title":"Drugs and lactation database (LactMed\u00ae)","year":"2025"},{"key":"10.1016\/j.neurot.2026.e00925_bib98","first-page":"162","article-title":"Sex differences in response to triptans","volume":"96","author":"van Casteren","year":"2021","journal-title":"Systemat Rev Meta-analys"},{"key":"10.1016\/j.neurot.2026.e00925_bib99","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0333102414544979","article-title":"Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis","volume":"35","author":"Chabi","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003088-200140030-00004","article-title":"Pharmacokinetics and pharmacodynamics of the Triptan antimigraine agents","volume":"40","author":"Jhee","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.neurot.2026.e00925_bib101","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0091270004268046","article-title":"Pharmacokinetics of Frovatriptan in adolescent migraineurs","volume":"44","author":"Elkind","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.neurot.2026.e00925_bib102","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/head.12640","article-title":"Systematic review of preventive and acute treatment of menstrual migraine","volume":"55","author":"Nierenburg","year":"2015","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10194-011-0366-9","article-title":"Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan","volume":"12","author":"Savi","year":"2011","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10072-012-1044-7","article-title":"Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies","volume":"33","author":"Allais","year":"2012","journal-title":"Neurol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2026.e00925_bib105","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s10072-013-1393-x","article-title":"Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies","volume":"34","author":"Allais","year":"2013","journal-title":"Neurol Sci : Off J Ital Neurol So Ital Soc Clin Neurophysiol"},{"key":"10.1016\/j.neurot.2026.e00925_bib106","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2165\/00023210-200620120-00005","article-title":"Efficacy and tolerability of Zolmitriptan oral tablet in the acute treatment of menstrual migraine","volume":"20","author":"Tuchman","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurot.2026.e00925_bib107","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1526-4610.2004.04027.x","article-title":"Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study","volume":"44","author":"Loder","year":"2004","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib108","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1526-4610.2008.01093.x","article-title":"Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine","volume":"48","author":"Nett","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib109","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1526-4610.2010.01771.x","article-title":"Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database","volume":"51","author":"Rodgers","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1526-4610.2007.00947.x","article-title":"Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (treat A migraine early) studies","volume":"48","author":"Martin","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib111","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1468-1331.2005.01076.x","article-title":"Efficacy of oral naratriptan in the treatment of menstrually related migraine","volume":"12","author":"Massiou","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10194-005-0156-3","article-title":"Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan","volume":"6","author":"Dowson","year":"2005","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib113","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1368-5031.2004.00295.x","article-title":"Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine","volume":"58","author":"Landy","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.neurot.2026.e00925_bib114","first-page":"835","article-title":"Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine","volume":"102","author":"Nett","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.neurot.2026.e00925_bib115","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/jwh.2008.1031","article-title":"Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study","volume":"18","author":"Newman","year":"2009","journal-title":"J Womens Health"},{"key":"10.1016\/j.neurot.2026.e00925_bib116","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0333102410378048","article-title":"Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study","volume":"31","author":"Allais","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib117","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/head.12257","article-title":"Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials","volume":"54","author":"Bhambri","year":"2014","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib118","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/head.12500","article-title":"Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis","volume":"55","author":"Marchenko","year":"2015","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib119","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00415-021-10534-5","article-title":"A systematic review and meta-analyses on the prevalence of pregnancy outcomes in migraine treated patients: a contribution from the IMI2 ConcePTION project","volume":"269","author":"Dudman","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.01.005","article-title":"Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?","volume":"186","author":"Rubio-Beltran","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neurot.2026.e00925_bib121","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3181\/00379727-210-43941","article-title":"Sumatriptan (Imitrex) transport by the human placenta","volume":"210","author":"Schenker","year":"1995","journal-title":"Proc Soc Exp Biol Me Soc Exp Biol Med (New York, NY)"},{"key":"10.1016\/j.neurot.2026.e00925_bib122","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2125.1996.tb00185.x","article-title":"Distribution and excretion of sumatriptan in human milk","volume":"41","author":"Wojnar-Horton","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neurot.2026.e00925_bib123","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/head.12064","article-title":"Use of common migraine treatments in Breast-feeding women: a summary of recommendations","volume":"53","author":"Hutchinson","year":"2013","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib124","doi-asserted-by":"crossref","DOI":"10.1177\/03331024241238153","article-title":"Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex","volume":"44","author":"Porreca","year":"2024","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib125","doi-asserted-by":"crossref","DOI":"10.1177\/03331024251320610","article-title":"Efficacy of ubrogepant and atogepant in males and females with migraine: a secondary analysis of randomized clinical trials","volume":"45","author":"Goadsby","year":"2025","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib126","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/head.14619","article-title":"Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: a post hoc analysis","volume":"63","author":"MacGregor","year":"2023","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib127","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1526-4610.1990.hed3011705.x","article-title":"Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study","volume":"30","author":"Sances","year":"1990","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib128","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1468-2982.2009.01840.x","article-title":"Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks","volume":"29","author":"Brandes","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib129","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1526-4610.2009.01513.x","article-title":"Safety and tolerability of short-term preventive Frovatriptan: a combined analysis","volume":"49","author":"MacGregor","year":"2009","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/01.WNL.0000134620.30129.D6","article-title":"A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine","volume":"63","author":"Silberstein","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib131","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1526-4610.2007.00855.x","article-title":"Efficacy and tolerability of Naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies","volume":"47","author":"Mannix","year":"2007","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib132","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/brain\/awaa211","article-title":"Differential medication overuse risk of novel anti-migraine therapeutics","volume":"143","author":"Saengjaroentham","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2026.e00925_bib133","article-title":"Rimegepant 75 mg for acute treatment of migraine is associated with significant reduction in monthly migraine days: results from a long-term, open-label study","volume":"5","author":"L\u2019Italien","year":"2022","journal-title":"Cephalalgia Rep"},{"key":"10.1016\/j.neurot.2026.e00925_bib134","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s10194-025-02185-y","article-title":"Short-term prevention of perimenstrual migraine with rimegepant","volume":"26","author":"Frank","year":"2025","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/head.12035","article-title":"Contraception and headache","volume":"53","author":"MacGregor","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib136","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.neurot.2026.e00925_bib137","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","article-title":"Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval","volume":"47","author":"Sulak","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.neurot.2026.e00925_bib138","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/jwh.2013.4485","article-title":"Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines","volume":"23","author":"Coffee","year":"2014","journal-title":"J Womens Health"},{"key":"10.1016\/j.neurot.2026.e00925_bib139","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.fertnstert.2011.07.1089","article-title":"Combined oral contraceptives in women with menstrual migraine without aura","volume":"96","author":"De Leo","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.neurot.2026.e00925_bib140","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/0333102417710636","article-title":"Effectiveness of the progestin-only pill for migraine treatment in women: a systematic review and meta-analysis","volume":"38","author":"Warhurst","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib141","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/154099903322643956","article-title":"Postmenopausal hormone therapy and migraine headache","volume":"12","author":"Misakian","year":"2002","journal-title":"J Womens Health"},{"key":"10.1016\/j.neurot.2026.e00925_bib142","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-1331.2006.01557.x","article-title":"Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study","volume":"14","author":"Aegidius","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib143","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1526-4610.2000.00027.x","article-title":"Predictability of exogenous hormone effect on subgroups of migraineurs","volume":"40","author":"Mueller","year":"2000","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib144","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s10194-018-0896-5","article-title":"Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)","volume":"19","author":"Sacco","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib145","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrd3551","article-title":"Development of subtype-selective oestrogen receptor-based therapeutics","volume":"10","author":"Nilsson","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurot.2026.e00925_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","volume":"130","author":"Stanczyk","year":"2024","journal-title":"Contraception"},{"key":"10.1016\/j.neurot.2026.e00925_bib147","series-title":"Atlas of headache disorders and resources in the world 2011","author":"World Health","year":"2011"},{"key":"10.1016\/j.neurot.2026.e00925_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003225.pub2","article-title":"Propranolol for migraine prophylaxis","volume":"2","author":"Linde","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurot.2026.e00925_bib149","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231183166","article-title":"The effect of blood pressure lowering medications on the prevention of episodic migraine: a systematic review and meta-analysis","volume":"43","author":"Carcel","year":"2023","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib150","first-page":"468","article-title":"Sex differences in pharmacokinetics of oral propranolol in healthy Chinese volunteers","volume":"16","author":"Xie","year":"1995","journal-title":"Zhongguo yao li xue bao = Acta pharmacologica Sinica"},{"key":"10.1016\/j.neurot.2026.e00925_bib151","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1989.136","article-title":"Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects","volume":"46","author":"Walle","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.neurot.2026.e00925_bib152","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/clpt.1994.115","article-title":"Propranolol metabolism in normal subjects: association with sex steroid hormones","volume":"56","author":"Walle","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.neurot.2026.e00925_bib153","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/acn3.51640","article-title":"Trigeminovascular effects of propranolol in men and women, role for sex steroids","volume":"9","author":"Rubio-Beltran","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib154","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-444-64240-0.00011-8","article-title":"Migraine and other headache disorders in pregnancy","volume":"172","author":"van Casteren","year":"2020","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib155","doi-asserted-by":"crossref","DOI":"10.1177\/03331024251332519","article-title":"Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: the unmet need of perimenstrual headache days","volume":"45","author":"Mas-de-les-Valls","year":"2025","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib156","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000207375","article-title":"Pregnancy outcomes in patients exposed to OnabotulinumtoxinA treatment: a cumulative 29-Year safety update","volume":"101","author":"Brin","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00925_bib157","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s10194-020-01196-1","article-title":"OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients","volume":"21","author":"Wong","year":"2020","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib158","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1517\/17425255.2011.544250","article-title":"Sex differences in pharmacokinetics of antidepressants","volume":"7","author":"Kokras","year":"2011","journal-title":"Expert Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.neurot.2026.e00925_bib159","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/EDE.0b013e31829e0aaa","article-title":"Antidepressant use and risk for preeclampsia","volume":"24","author":"Palmsten","year":"2013","journal-title":"Epidemiology"},{"key":"10.1016\/j.neurot.2026.e00925_bib160","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2014.1891","article-title":"Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial","volume":"174","author":"Joffe","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.neurot.2026.e00925_bib161","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","article-title":"The efficacy and safety of venlafaxine in the prophylaxis of migraine","volume":"45","author":"Ozyalcin","year":"2005","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib162","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/WNF.0b013e3181a8c84f","article-title":"Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders","volume":"32","author":"Tarlaci","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neurot.2026.e00925_bib163","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.2010.2016","article-title":"Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial","volume":"305","author":"Freeman","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.neurot.2026.e00925_bib164","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2053369117731172","article-title":"Migraine, menopause and hormone replacement therapy","volume":"24","author":"MacGregor","year":"2018","journal-title":"Post Reprod Health"},{"key":"10.1016\/j.neurot.2026.e00925_bib165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"Veroniki","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.neurot.2026.e00925_bib166","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib167","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0333102410378049","article-title":"Perimenstrual migraines and their response to preventive therapy with topiramate","volume":"31","author":"Allais","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib168","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"10.1016\/j.neurot.2026.e00925_bib169","series-title":"Candesartan. Drugs and lactation database (LactMed\u00ae)","year":"2006"},{"key":"10.1016\/j.neurot.2026.e00925_bib170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/164_2019_204","article-title":"Understanding CGRP and cardiovascular risk","volume":"255","author":"Rubio-Beltran","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neurot.2026.e00925_bib171","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ahj.2007.10.019","article-title":"Angina with \u201cnormal\u201d coronary arteries: sex differences in outcomes","volume":"155","author":"Humphries","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.neurot.2026.e00925_bib172","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0735-1097(94)00507-M","article-title":"Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study","volume":"25","author":"Kaski","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.neurot.2026.e00925_bib173","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.110.165993","article-title":"Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries","volume":"334","author":"Chan","year":"2010","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.neurot.2026.e00925_bib174","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.RES.73.3.579","article-title":"Peptidergic innervation of human epicardial coronary arteries","volume":"73","author":"Gulbenkian","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.neurot.2026.e00925_bib175","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s10194-021-01336-1","article-title":"Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study","volume":"22","author":"MaassenVanDenBrink","year":"2021","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib176","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fneur.2021.774341","article-title":"Gender differences in 3-Month outcomes of Erenumab Treatment\u2014study on efficacy and safety of treatment with Erenumab in men","volume":"12","author":"Ornello","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib177","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s40122-021-00273-w","article-title":"Effectiveness and safety of CGRP-mAbs in menstrual-related migraine: a real-world experience","volume":"10","author":"Silvestro","year":"2021","journal-title":"Pain Ther"},{"key":"10.1016\/j.neurot.2026.e00925_bib178","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40120-022-00410-3","article-title":"Galcanezumab effects on migraine severity and symptoms in Japanese patients with episodic migraine: secondary analysis of a phase 2 randomized trial","volume":"12","author":"Igarashi","year":"2023","journal-title":"Neurol Ther"},{"key":"10.1016\/j.neurot.2026.e00925_bib179","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/head.14652","article-title":"Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: a post hoc analysis of EVOLVE-1 and EVOLVE-2","volume":"64","author":"MacGregor","year":"2024","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s10194-020-01167-6","article-title":"Efficacy and safety of erenumab in women with a history of menstrual migraine","volume":"21","author":"Pavlovic","year":"2020","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurot.2026.e00925_bib181","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/ene.15794","article-title":"Both perimenstrual and nonperimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies","volume":"30","author":"Verhagen","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurot.2026.e00925_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11030370","article-title":"Menstrual headache in women with chronic migraine treated with erenumab: an observational case series","volume":"11","author":"Ornello","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.neurot.2026.e00925_bib183","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1095\/biolreprod67.2.624","article-title":"Infusion of pregnant rats with calcitonin gene-related peptide (CGRP)8-37, a CGRP receptor antagonist, increases blood pressure and fetal mortality and decreases fetal Growth1","volume":"67","author":"Gangula","year":"2002","journal-title":"Biol Reprod"},{"key":"10.1016\/j.neurot.2026.e00925_bib184","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/aogs.15115","article-title":"Association between migraine, migraine subtype, and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"104","author":"Hansen","year":"2025","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.neurot.2026.e00925_bib185","doi-asserted-by":"crossref","DOI":"10.1177\/03331024241273966","article-title":"Case series on monoclonal antibodies targeting calcitonin gene-related peptide in migraine patients during pregnancy: enhancing safety data","volume":"44","author":"Elosua-Bayes","year":"2024","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib186","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1177\/0333102420983292","article-title":"Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: analysis of the WHO pharmacovigilance database","volume":"41","author":"Noseda","year":"2021","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib187","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.yrtph.2019.05.013","article-title":"Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine","volume":"106","author":"Bussiere","year":"2019","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.neurot.2026.e00925_bib188","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s13311-018-0622-7","article-title":"The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy","volume":"15","author":"Raffaelli","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2026.e00925_bib189","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/bfm.2021.0110","article-title":"Monoclonal antibodies during breastfeeding","volume":"16","author":"Anderson","year":"2021","journal-title":"Breastfeed Med : Off J Aca Breastfeed Med"},{"key":"10.1016\/j.neurot.2026.e00925_bib190","article-title":"International headache Society global practice recommendations for preventive pharmacological treatment of migraine","volume":"44","author":"Puledda","year":"2024","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib191","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0333102419884943","article-title":"Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries","volume":"40","author":"Rubio-Beltran","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib192","doi-asserted-by":"crossref","DOI":"10.1177\/03331024251393945","article-title":"Migraine management during pregnancy, breastfeeding and in women planning pregnancy","volume":"45","author":"Ornello","year":"2025","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurot.2026.e00925_bib193","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s40120-025-00772-4","article-title":"Pharmacokinetics of atogepant in healthy lactating female participants: results from a phase 1 lactation study","volume":"14","author":"Boinpally","year":"2025","journal-title":"Neurol Ther"},{"key":"10.1016\/j.neurot.2026.e00925_bib194","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/bfm.2021.0250","article-title":"Human milk and plasma pharmacokinetics of single-dose rimegepant 75 mg in healthy lactating women","volume":"17","author":"Baker","year":"2022","journal-title":"Breastfeed Med : Off J Aca Breastfeed Med"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:26:39Z","timestamp":1780777599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":194,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1878747926000954"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00925","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-specific considerations in migraine therapy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00925"}}